According to the clinic, these side effects should be reported to your care team as soon as possible. For Lloyd, only 3 days ...

Mounjaro, one of the brand names for tirzepatide, is a drug that is beneficial for people with type 2 diabetes. This ...

Eli Lilly’s diabetes and obesity management drug Mounjaro saw a sharp rise in sales for the third consecutive month, driven ...

Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels ...

That went OK. Then came the move to 5mg, always taken religiously on what I’ve dubbed Mounjaro Monday. What once felt like a weekly superpower injection felt more like an engine quietly losing ...

The various trials covered time periods ranging from 40 to 52 weeks and included three different strengths of Mounjaro: 5 mg, 10 mg, and 15 mg. The primary endpoint for all the SURPASS trials was ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...

Chugai plans to pair its muscle-preserving drug with Eli Lilly's orforglipron, addressing muscle loss in obesity care as the ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has experienced a 60% sales increase in India between April and May.

Many ICBs have not yet finalised plans for Mounjaro delivery in primary care, despite the NICE deadline being less than three ...

The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...